Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MitescoMITI +12.54% Days Sales Outstanding is 0.00 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 655 Healthcare Providers & Services companies, Mitesco ranks worse than 98.93% on this metric.
Mitesco's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.03 Mil. Mitesco's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil.
The historical rank and industry rank for Mitesco's Days Sales Outstanding or its related term are showing as below:
MITI'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 138.45 Med: 248.86 Max: 560.77
Current: 560.77
During the past 13 years, Mitesco's highest Days Sales Outstanding was 560.77. The lowest was 138.45. And the median was 248.86.
MITI's Days Sales Outstanding is ranked worse than 98.93% of 655
companies
in the Healthcare Providers & Services industry
Industry Median: 47.32
vs MITI: 560.77
Mitesco's Days Sales Outstanding
declined
from Mar. 2025 (198.60) to Mar. 2026 (0.00).
Warning Sign:
If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.
Mitesco (OTCPK:MITI) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Mitesco Days Sales Outstanding Related Terms
Mitesco Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Mitesco's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MITI vs DOGP, ESSI, ZCMD: Days Sales Outstanding Comparison
For the Health Information Services subindustry, Mitesco's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mitesco Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mitesco's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Mitesco's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mitesco (MITI) has a Days Sales Outstanding of 0.00 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Mitesco and its competitors. Over the past decade, Mitesco's Days Sales Outstanding has ranged from 138.45 to 560.77. According to the industry distribution chart, Mitesco ranks #648 out of 655 companies in the Healthcare Providers & Services industry, placing it in the top 98.9%.
Is Mitesco's Days Sales Outstanding too high?
Mitesco's current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 138.45 to a high of 560.77. Based on the distribution chart, Mitesco ranks #648 out of 655 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Mitesco's Days Sales Outstanding compare to DOGP and ESSI?
According to the Healthcare Providers & Services industry distribution chart, Mitesco ranks #648 out of 655 companies for Days Sales Outstanding. This places Mitesco in the lower half of its industry. The industry median Days Sales Outstanding is 47.32. Historically, Mitesco's own Days Sales Outstanding has ranged from 138.45 to 560.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 47.32, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Mitesco and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 47.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mitesco's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mitesco stock overvalued right now?
Mitesco (MITI) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Mitesco (MITI), the current Days Sales Outstanding is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mitesco Inc is a holding company focused on developing products, services, and technology solutions through its wholly owned subsidiaries. The company, through its subsidiaries, provides data center services, cloud computing, application hosting, and managed services offerings, pursues investment, acquisition, and internal development opportunities in cloud computing, data center applications, and artificial intelligence software solutions. The company is also developing AI-driven products, including Robo Agent, and evaluating additional cloud-based software opportunities. The firm principally earns revenue by providing generic data center services, which is aimed at hosting applications for a specific user, sometimes referred to as "managed services offerings" or MSO.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MITI has been successfully added to your 
